Pfizer-BioNTech Omicron-specific vaccine delayed, but might not be needed

Portfolio
Delivery of Pfizer and BioNTech SE's vaccine to combat the Omicron COVID-19 variant was delayed by several weeks due to a slower-than-expected data gathering process, BionTech Chief Executive Ugur Sahin told Germany's Bild on Thursday, Reuters reported.

Once the vaccine is ready, the company would assess whether it was still needed, Sahin said.

"If the wave ends, that does not mean it can't begin again," he told Bild in a video interview, adding that BioNTech was in a position to continue creating new vaccines as variants emerged if needed.

I really don't see the situation as dramatic anymore,

he said, referring to how the coronavirus would develop in future.

BioNTech had previously expected to launch the vaccine by end of March, but said in late January that this depended on how much clinical data regulators would require.

 

More in Business

May 17, 2024 08:32

EU keeps a close eye on ‘spread of disinformation’ on Fico shooting

Commission warns tech giants

bezárás
May 16, 2024 18:15

Number of businesses operating in Hungary keeps on dropping

January-April terminations second worst since 2018

telekommunikáció távközlés telekom
May 16, 2024 09:42

Hungary Magyar Telekom raises profit target - What about the dividend?

Good news in Q1 2024 earnings report

telekom székház
May 15, 2024 08:30

We'll find out today how Hungary's Magyar Telekom fared in the first quarter of 2024

Analysts' consensus estimates published

May 14, 2024 13:06

Hungary EcoMin visits China's Nio

Talks with Nio Europe Vice President

LATEST NEWS

Detailed search